• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非典型慢性髓细胞白血病

Atypical chronic myeloid leukemias.

作者信息

Oscier D

机构信息

Royal Bournemouth Hospital, Department of Haematology, UK.

出版信息

Pathol Biol (Paris). 1997 Sep;45(7):587-93.

PMID:9404484
Abstract

An ideal classification of the chronic myeloid leukemias would be based on a thorough understanding of the aetiology, pathogenesis, clinical and laboratory features, and natural history of the various conditions which comprise CML. Only in the case of CGL is the pathogenesis well understood and the diagnosis of the remaining disorders is still largely based on clinical and morphological criteria. It is inevitable for the reasons previously discussed that there will be cases which either defy classification or fall within the diagnostic criteria of more than one disorder. As long as careful clinical and morphological observation continues in parallel with advances in cellular and molecular biology it seems inevitable that the current debate about the inter-relationship between CMML, aCML and Philadelphia negative CGL will be resolved.

摘要

慢性髓系白血病的理想分类应基于对构成慢性粒细胞白血病(CML)的各种病症的病因、发病机制、临床和实验室特征以及自然史的透彻理解。只有慢性粒细胞白血病(CGL)的发病机制得到了很好的理解,而其余病症的诊断仍主要基于临床和形态学标准。基于先前讨论的原因,不可避免地会出现一些病例,它们要么难以分类,要么符合一种以上病症的诊断标准。只要在细胞和分子生物学取得进展的同时继续进行仔细的临床和形态学观察,目前关于慢性粒-单核细胞白血病(CMML)、不典型慢性粒细胞白血病(aCML)和Ph阴性慢性粒细胞白血病(CGL)之间相互关系的争论似乎必然会得到解决。

相似文献

1
Atypical chronic myeloid leukemias.非典型慢性髓细胞白血病
Pathol Biol (Paris). 1997 Sep;45(7):587-93.
2
Management of the chronic leukemias: special considerations in the elderly patient. Part III rarer chronic myeloid leukemias.慢性白血病的管理:老年患者的特殊考量。第三部分 罕见的慢性髓系白血病
Hematology. 2002 Feb;7(1):1-8. doi: 10.1080/10245330290020072.
3
The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.外周血、骨髓穿刺液,尤其是骨髓活检切片在鉴别不典型慢性髓细胞白血病与慢性粒细胞白血病及慢性粒单核细胞白血病中的作用。
Eur J Haematol. 2009 Oct;83(4):292-301. doi: 10.1111/j.1600-0609.2009.01283.x. Epub 2009 Jun 2.
4
Clinical, morphological, cytogenetic and molecular aspects of a series of Ph-negative chronic myeloid leukemias.一系列Ph阴性慢性髓性白血病的临床、形态学、细胞遗传学及分子学特征
Hematol Cell Ther. 1998 Aug;40(4):149-58.
5
Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.诊断骨髓增生异常/骨髓增殖性肿瘤:排除其他疾病的实验室检测策略。
Int J Lab Hematol. 2010 Dec;32(6 Pt 2):559-71. doi: 10.1111/j.1751-553X.2010.01251.x.
6
p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders?p190 bcr-abl重排:某些慢性髓系疾病中的一种继发性细胞遗传学事件?
Haematologica. 1999 Dec;84(12):1075-80.
7
Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.异基因移植:骨髓纤维化、慢性粒单核细胞白血病及费城染色体阴性/BCR-ABL阴性慢性粒细胞白血病的一种治疗选择。
Bone Marrow Transplant. 2004 May;33(10):1005-9. doi: 10.1038/sj.bmt.1704472.
8
[Diagnostic spectrum of Philadelphia-chromosome negative leukemic disorders].[费城染色体阴性白血病性疾病的诊断谱]
Pathologe. 2002 Nov;23(6):448-56. doi: 10.1007/s00292-002-0585-6. Epub 2002 Oct 19.
9
Presence of t(1;14)(p13;p11.2) in Philadelphia chromosome-negative cells in a patient with chronic myeloid leukemia.
Cancer Genet Cytogenet. 2007 Feb;173(1):83-4. doi: 10.1016/j.cancergencyto.2006.10.003.
10
Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.费城染色体阴性、bcr/abl阴性慢性粒细胞白血病患者的特征及预后
Cancer. 2002 Oct 15;95(8):1673-84. doi: 10.1002/cncr.10832.

引用本文的文献

1
Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Differential Diagnosis in the WHO and ICC 2022 Era: A Focused Review.2022年世界卫生组织(WHO)和国际癌症研究机构(ICC)时代的骨髓增生异常综合征/骨髓增殖性重叠肿瘤及其鉴别诊断:重点综述
Cancers (Basel). 2023 Jun 13;15(12):3175. doi: 10.3390/cancers15123175.
2
Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders - Epidemiological Features and Overview.混合性或重叠性骨髓增生异常/骨髓增殖性疾病——流行病学特征与概述
Front Oncol. 2021 Nov 16;11:778741. doi: 10.3389/fonc.2021.778741. eCollection 2021.
3
Molecular Pathogenesis of -Negative Atypical Chronic Myeloid Leukemia.
阴性非典型慢性髓系白血病的分子发病机制
Front Oncol. 2021 Nov 11;11:756348. doi: 10.3389/fonc.2021.756348. eCollection 2021.
4
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia.非典型慢性髓性白血病的综合基因组、功能和预后特征分析
Hemasphere. 2020 Nov 6;4(6):e497. doi: 10.1097/HS9.0000000000000497. eCollection 2020 Dec.